ERBB2 and hepatocellular carcinoma: Given that DDOST/STT3A knockdown cosuppresses ERBB2 (a heterodimer of EGFR) signaling (Supplementary Fig. 8c) and aberrant EGFR activation contributes to lenvatinib resistance, we next investigated whether DDOST regulates lenvatinib resistance in HCC cells.